TLSI EPS Estimates
TriSalus Life Sciences, Inc.
$4.06
-$0.07(-1.69%)
33
Overall
40
Value
10
Tech
50
Quality
Market Cap
$249.99M
Volume
198.96K
52W Range
$2.20 - $7.95
Target Price
$10.40
TLSI EPS estimates: the consensus estimate for TriSalus Life Sciences, Inc.'s current fiscal year is -$0.53 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TLSI EPS Estimates
- EPS estimate, current quarter
- $-0.14
- EPS estimate, next quarter
- $-0.04
- EPS estimate, current year
- $-0.53
- EPS estimate, next year
- $-0.28
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.84 |
| 2024 | $-1.31 |
| 2023 | $-6.73 |
| 2022 | $0.19 |
| 2021 | $0.30 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TLSI | $4.06 | -1.7% | 198.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get TriSalus Life Sciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW